Back

Medscape, LLC

  • Illicit Drugs
  • Medetomidine

Medscape Now! Medetomidine Withdrawal: Recognizing and Managing a Novel Life-Threatening Drug Syndrome

The goal of this activity is for learners, as members of the healthcare team, to be able to recognize the clinical features of medetomidine withdrawal and implement appropriate management strategies to improve patient safety amid the evolving illicit drug landscape.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

ABIM — Medical KnowledgeUp to 0.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • MOC · Up to 0.25 points
  • Released
    Apr 6, 2026
  • Last day to claim credit
    Apr 6, 2029 2 years left